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Abstract: Five new oxygenated pimarane diterpenes, named scopararanes C–G (1–5) were 
isolated from the culture of a marine sediment-derived fungus Eutypella scoparia FS26 
obtained from the South China Sea. The structures of these compounds were established on 
the basis of extensive spectroscopic analysis. The absolute configurations of compounds  
1–5, were determined by CD spectroscopic analysis and comparison with literature data. 
All isolated compounds (1–5) were evaluated for their cytotoxic activities against MCF-7, 
NCI-H460, and SF-268 tumor cell lines by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
2H-tetrazolium bromide (MTT) method. 
Keywords: pimarane diterpenes; marine sediment-derived fungus; Eutypella scoparia; 
South China Sea; cytotoxic activity 
 
1. Introduction  
In recent years, the rich and unprecedented chemical diversity of natural products from   
marine-derived fungi and their pronounced biological activities continue to attract the interest of 
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natural product chemists, ecologists and pharmacologists alike [1–5]. The total number of new natural 
products from marine-derived fungi had already exceeded 1000 by the end of the year 2010, and 
approximately 16% of the new natural products were isolated from sediments [6]. Recently, we isolated a 
fungus strain, Eutypella scoparia FS26 from marine sediment. 
Eutypella species are present in a diverse array of habitats, including soil in Antarctica and tropical 
forests of Australia and Thailand. It was also found in the marine pulmonate mollusc Onchidium sp. [7]. 
Although only few chemical investigations of the genus Eutypella were reported, the numerous 
secondary metabolites from this genus were isolated, including polyketides such as γ-lactones, 
benzopyran derivatives and cytosporin-related compounds, terpenoids such as ent-eudesmane 
sesquiterpenes, and pimarane diterpenes, and nitrogenous compounds such as cytochalasin derivatives 
and cyclic dipeptides [7–10]. Previously, we have reported eleven terpenoids, five ergosterol derivatives, 
and two nitrogen-containing metabolites from the culture of E. scoparia FS26 [11–13]. Among these 
terpenoids, there were six known pimarane diterpenes, libertellenone A (6), scopararane B (7), 
diaporthein A (8), diaporthein B (9), 11-deoxydiaporthein A (10), and isopimara-8(14),15-diene (11). 
We now report the isolation, structure elucidation and cytotoxicity of five new pimarane diterpenes, 
scopararanes C–G (1–5) (Figure 1).  
Figure 1. Chemical structures of compounds 1–11. 
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2. Results and Discussion  
The fungus E. scoparia FS26 was isolated from a marine sediment sample from the South China  
Sea. It was cultured in potato dextrose broth (PDB) in 50% (v/v) sea water. The culture (100 L) was 
centrifuged to separate broth and mycelia, followed by extraction with ethyl acetate. The concentrated Mar. Drugs 2012, 10                 
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extracts were further purified by various chromatographic methods including silica gel, reversed-phase 
silica gel C18, and Sephadex LH-20 to yield scopararanes C–G (1–5). 
2.1. Structural Elucidation 
Scopararane C (1) was obtained as colorless crystals. The molecular formula, C20H28O3, consistent 
with seven degrees of unsaturation, was determined by HR-EI-MS (m/z 316.2032, [M]
+, C20H28O3
+; 
calcd 316.2033). The 
1H NMR spectrum of 1 demonstrated signals characteristic of terminal vinylic 
protons at [δH 5.87 (1H, dd, J = 17.5, 10.7 Hz, H-15), 5.10 (1H, dd, J = 17.5 Hz, 0.7 Hz , H-16a), and 
5.06 (1H, dd, J = 10.7, 0.7 Hz, H-16b)] , an olefinic proton at [δH 7.04 (1H, d, J = 1.8 Hz, H-14)], and 
four tertiary methyl groups at [δH 1.41 (3H, s, H-18), 1.29 (3H, s, H-19), 1.21 (3H, s, H-20), and 1.13 
(3H, s, H-17)] (Table 1; all spectra are provided as supplementary material). Analyses of 
1H, 
13C, 
DEPT135 and HSQC NMR data (Table 1) revealed that scopararane C contains 20 carbons including 
four singlet methyls, six methylenes (one sp
2 and five sp
3), two sp
2 methines, and eight quaternary 
carbons (one α,β-unsaturated carbonyl, an oxygenated sp
2, two sp
2, an oxygenated sp
3, and three sp
3). 
The 
1H and 
13C NMR spectra of 1 were similar to those reported earlier for pimarane-type diterpene 
libertellenone A (6) [12,14], except the oxymethine at [δH 4.34 (dd, J  = 9.5, 5.5 Hz, H-1);   
δC 69.3)] in 6 was replaced by the methylene at [δH 1.98 (m), 1.53 (m); δC 30.6)] in 1, and the chemical 
shift of C-2 (δC 17.7) in 1 was upfield shifted by ∆δ 11.5 ppm compared with that of C-2 (δC 29.2) in 6 
(Table 1). 
1H,
1H-COSY spectrum of 1 revealed the partial structure H-1 to H-3 via H-2, the 
connectivity between H-11 and H-12, and also the connectivity between H-15 and H-16 (Figure 2). 
The observed HMBC correlations from H-18 to C-3, C-4, C-5 and C-19, H-19 to C-3, C-4, C-5   
and C-18, H-20 to C-1, C-5, C-9, and C-10, H-17 to C-12, C-13, C-14, and C-15, H-15 to C-12, C-13, 
C-14, and C-17, H-14 to C-7, C-8 and C-9, H-12 to C-9, and 6-OH to C-5, C-6, and C-7 (Figure 2), 
further confirmed the structure for 1. The relative configuration of 1 was identical to that in 
libertellenone A (6) according to proton coupling constants and NOESY spectrum results (Figure 3). 
The coupling constants of H-11β (ddd, J = 12.4, 12.4, 3.2 Hz) showed the characteristics of geminal 
and axial-axial relationships, which indicated the pseudoaxial position of H-11β. H-11β showed NOE 
correlations with H-17 and H-20, and H-20 showed NOE correlation with H-19, demonstrating that  
C-17, C-19, and C-20 are in axial configurations on the top face of the molecule. The hydroxyl group 
at C-9 was established as beta-axial based upon the NOE correlation between H-11β and H-20. 
Table 1. 
1H and 
13C NMR spectroscopic data of compounds 1–3. 
Position 
1 
a 2 
a 3 
b 
δC, mult.  δH (J in Hz)  δC, mult.  δH (J in Hz)  δC, mult.  δH (J in Hz) 
1α 30.6,  CH2 1.98,  m  28.8,  CH2  2.12, ddd (13.0, 13.0, 4.1)  32.0, CH2  2.18, ddd (13.5, 13.5, 4.7) 
1β  1.53, m  1.59, m  1.85, ddd (13.5, 4.2, 1.6) 
2 17.7,  CH2 1.65,  2m  25.7,  CH2 1.78,  2m  26.7,  CH2 1.74,  2m 
3 41.4,  CH2 1.55,  m;  1.45, m  76.8, CH  3.42, dd (11.4, 4.5)  77.7, CH  3.40, dd (11.1, 5.0) 
4  35.4, C    40.7, C    41.8, C   
5  142.8, C    143.3, C    145.6, C   
6  144.4, C  6.73, s (OH)  145.0, C    144.9, C   
7  181.6, C    182.1, C    183.3, C   Mar. Drugs 2012, 10                 
 
 
542
Table 1. Cont. 
Position 
1 
a 2 
a 3 
b 
δC, mult.  δH (J in Hz)  δC, mult.  δH (J in Hz)  δC, mult.  δH (J in Hz) 
8  133.7, C    133.8, C    134.9, C   
9  74.1, C    73.6, C    76.1, C   
10  45.1, C    44.6, C    46.7, C   
11α 25.2,  CH2  1.81, ddd (12.4, 3.2, 2.4)  25.5, CH2 1.74,  m  65.8,  CH   
11β  1.93, ddd (12.4, 12.4, 3.2)  2.03, ddd (13.6, 13.6, 3.0)  4.23, dd (12.1, 4.2) 
12α 29.5,  CH2  1.88, ddd (12.4, 12.4, 3.2)  29.1, CH2  1.92, ddd (13.6, 13.6, 3.0)  39.9, CH2 1.79,  m 
12β  1.58, m  1.59, m  1.65, ddd (12.1, 4.2, 1.9) 
13  38.8, C    38.4, C    40.1, C   
14  147.9, CH  7.04, d (1.8)  147.9, CH  6.95, d (1.8)  147.0, CH  6.94, d (1.8) 
15  145.4, CH  5.87, dd (17.5, 10.7)  145.4, CH  5.94, dd (17.5, 10.7)  146.1, CH  5.89, dd (17.5, 10.7) 
16a 112.6,  CH2  5.10, dd (17.5, 0.7)  111.3, CH2  5.13, dd (17.5, 0.9)  112.3, CH2  5.13, dd (17.5, 0.8) 
16b  5.06, dd (10.7, 0.7)  5.07, dd (10.7, 0.9)  5.05, dd (10.7, 0.8) 
17 23.3,  CH3 1.13,  s  22.3,  CH3 1.15,  s  24.0,  CH3 1.18,  s 
18 30.1,  CH3 1.41,  s  24.9,  CH3 1.55,  s  25.9,  CH3 1.54,  s 
19 26.9,  CH3 1.29,  s  18.1,  CH3 1.25,  s  19.0,  CH3 1.21,  s 
20 29.4,  CH3 1.21,  s  28.7,  CH3 1.22,  s  29.2,  CH3 1.24,  s 
a Measured in CDCl3; 
b Measured in CD3OD. 500 MHz for 
1H NMR; 125 MHz for 
13C NMR.  
Figure 2. Key HMBC (arrows) and COSY (bold lines) correlations of compound 1. 
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Figure 3. Key NOESY correlations of compounds 1 and 4, whose conformation was 
modeled by using the MM2 minimum energy calculation [15]. 
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Scopararane D (2) was obtained as colorless crystals. Its molecular formula, C20H28O4, was 
determined by HR-EI-MS (m/z 332.1983, [M]
+, C20H28O4
+; calcd 332.1982) indicating the presence of 
seven degrees of unsaturation. Comparison of the 
1H and 
13C NMR data with those of the scopararane 
C (1) revealed that the signals were similar, except one methylene signal at [δH 1.55 (m), 1.45 (m);  
δC 41.4] in 1 was absent, and one new hydroxyl-bearing methine was present in 2 at [δH 3.42 (dd,  
J = 11.4, 4.5 Hz); δC 76.8], which suggested that scopararane D (2) was the 3-hydroxyl derivative of 
scopararane C (1). The HMBC correlations observed between the proton at δH 3.42 (H-3) and the 
13C 
signals at δC 40.7 (C-4), 28.8 (C-1), 24.9 (C-18), and 18.1 (C-19), further confirmed the assignment of 
new hydroxyl group to the 3-position. The entire sequence of H-atoms and the C-skeleton of 2 was 
established by 
1H, 
1H-COSY and HMBC. The relative configuration of 2 was identical to that in 
libertellenone A (6) and scopararane C (1) according to proton coupling constants and NOESY 
spectrum data. The proton coupling constants of H-11β (ddd, J = 13.6, 13.6, 3.0 Hz), H-1α (ddd,  
J = 13.0, 13.0, 4.1 Hz), and H-3α (dd, J = 11.4, 4.5 Hz), indicated the axial orientations of H-11β,  
H-1α, and H-3α. H-11β showed NOE correlations with H-17 and H-20, and H-20 showed NOE 
correlation with H-19, indicated the beta-axial positions of Me-17, Me-19, and Me-20. H-3α showed 
NOE correlations with H-1α and H-18, in agreement with the beta-equatorial position of 3-OH. 
Scopararane E (3) was obtained as colorless crystals, which were analyzed for the molecular 
formula C20H28O5 (seven unsaturation equivalents) by HR-EI-MS (m/z 371.1833, [M + Na]
+, 
C20H28O5Na
+; calcd 371.1834). The 
1H NMR spectrum of 3 was similar to that of scopararane D (2), 
except the methylene proton signal at [δH 2.03 (ddd, J = 13.6, 13.6, 3.0 Hz), 1.74 (m)] in 2 was 
replaced by the oxymethine proton resonance in 3 at [δH 4.23 (dd, J = 12.1, 4.2 Hz)]. Comparison of 
the 
13C NMR data with those of 2 showed analogy of the chemical shifts except for C-11 and C-12. 
The above evidence suggested that scopararane E (3) was the 11-hydroxyl derivative of scopararane D (2). 
The HMBC correlations observed between the proton at δH 4.23 (H-11) and the 
13C signals at δC 39.9 
(C-12), and 46.7 (C-10), further confirmed the assignment of new hydroxyl group to the 11-position. 
Analyses of 
1H, 
1H COSY and HMBC spectral data allowed complete assignment of protons and 
carbons in 3 (Table 1). The relative configuration of 3 was identical to that in libertellenone A (6), 
scopararane C (1), and scopararane D (2) according to proton coupling constants and NOESY 
spectrum data. 
The absolute stereostructures of compounds 1–3 were determined on the basis of their CD spectra. 
The absolute configuration of libertellenone A had been established by the modified Mosher method 
and its CD spectra data had also been reported in the literature [14]. Our results showed that the CD 
spectra of compounds 1–3 were virtually identical to that of libertellenone A with all demonstrating a 
clear negative Cotton effect between 350 and 353 nm, which was derived from the π-π* transition of the 
cross-conjugated system. Compounds 1–3 also have the same positive Cotton effect as libertellenone A 
at 308–312 nm. Based on the above evidence, compounds 1–3 and 6 belong to the same stereochemical 
series. Thus, the absolute stereochemistry of 1 was established as 9S, 10S, and 13R, that of 2 as 3S, 9S, 
10S, and 13R, and that of 3 as 3S, 9S, 10S, 11R, and 13R.  
Scopararane F (4) was obtained as colorless crystals, having a molecular formula of C20H30O5  
(six unsaturation equivalents), determined by HR-EI-MS (m/z 373.1984, [M + Na]
+, C20H30O5Na
+; 
calcd 373.1991). The 
1H, 
13C, DEPT135 and HSQC NMR spectra of 4 showed 20 carbon signals and 
26 protons for three singlet methyls, seven methylenes (one sp
2, an oxygenated sp
3, and five sp
3), three Mar. Drugs 2012, 10                 
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methines (one sp
2, and two oxygenated sp
3), and seven quaternary carbons (two sp
2, two oxygenated 
sp
3, and three sp
3). Comparison of the 
1H and 
13C NMR data of 4 with those of scopararane B (7) [9,12] 
revealed similar signals, except one hydroxyl-bearing double doublet methine signal at [δH 4.42 (dd,  
J = 6.3, 4.8 Hz); δC 70.0], and the α,β-unsaturated ketone C-7 (δC 194.6) in 7 were absent, and one new 
methylene at [δH 2.19 (ddd, J = 13.6, 5.8, 2.9 Hz), 1.92 (m); δC 21.7], and a hydroxyl-bearing singlet 
methine signal at [δH 4.48 (s); δC 74.6] were present in 4. The new methylene protons and singlet 
methine signal were then attributed to H2-11 and H-7 respectively. HMBC cross-peaks of H-7 with C-6, 
C-8, and C-9, and H-11 with C-8, C-9, C-12, and C-13, further confirmed the 7-position of the methine 
and 11-position of the methylene respectively. Analyses of 
1H, 
1H COSY and HMBC spectral data 
allowed complete assignment of protons and carbons in 4 (Table 2). The relative configuration of 4 
was determined by analysis of the 
1H–
1H J-value and NOESY data (Figure 3). The small coupling 
constants of H-11α [δH 2.19 (dd, J = 5.8, 2.9 Hz)] with H-12, indicated the axial location of H-11β  
(δH 1.92). H-11β showed NOE correlations with H-17 and H-20b [δH 3.40 (d, J = 9.2 Hz)], and H-20a 
[δH 4.13 (d, J = 9.2 Hz)] showed NOE correlation with H-19, indicating the beta-axial orientation of 
Me-17, Me-19, and H-20. H-14 showed NOE correlations with H-7 and H-17, in agreement with 
alpha-axial positions of 7-OH and 14-OH. The relative configurations of C-7 and C-14 were identical 
to that in sphaeropsidin E [16]. Compound 4 has the same negative optical rotation as compounds 1–3 
and 6, and also has the same relative configuration as compounds 1–3 and 6. On the base of biogenetical 
reasons, the absolute configuration of compound 4 can be assumed to be similar to those of compounds 
1–3 and 6. Accordingly, the absolute stereochemistry of 4 was established as 6R, 7R, 8S, 10R, 13R, 
and 14S. 
Table 2. 
1H and
 13C NMR data of compounds 4–5. 
Position 
4 
b 5 
a 
δC, mult.  δH (J in Hz)  δC, mult.  δH (J in Hz) 
1 24.8,  CH2  1.55, 2m  29.1, CH2 1.63,  2m 
2 18.9,  CH2  1.61, 2m  17.9, CH2 1.67,  2m 
3 38.7,  CH2  1.64, m; 1.11, m  36.3, CH2  1.71, m; 1.53, m 
4  37.4, C    36.7, C   
5  80.0, C    82.6, C   
6  107.2, C    210.9, C   
7  74.6, CH  4.48, s  74.6, CH  5.23, s 
8  132.6, C    131.8, C   
9  141.7, C    139.8, C   
10  52.1, C    50.7, C   
11α 21.7,  CH2  2.19, ddd (13.6, 5.8, 2.9)  21.2, CH2 2.15,  m 
11β  1.92, m  1.90, m 
12α 28.0,  CH2  1.80, m  30.2, CH2 1.83,  m 
12β  1.41, m  1.49, m 
13  39.6, C    39.7, C   
14  70.6, CH  4.01, s  72.4, CH  4.13, s 
15  146.2, CH  6.07, dd (17.5, 11.1)  142.0, CH  6.03, dd (17.3, 1.4) 
16a 112.1,  CH2  5.07, dd (17.5, 1.5)  114.8, CH2  5.23, dd (17.3, 1.4) 
16b  5.05, dd (11.1, 1.5)  5.21, dd (11.4, 1.4) Mar. Drugs 2012, 10                 
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Table 2. Cont. 
Position 
4 
b 5 
a 
δC, mult.  δH (J in Hz)    δC, mult. 
17 21.3,  CH3  0.93, s  22.8, CH3 1.08,  s 
18 24.3,  CH3  1.46, s  23.8, CH3 1.46,  s 
19 28.9,  CH3  1.23, s  27.8, CH3 1.07,  s 
20 72.4,  CH2  4.13, d (9.2)  23.5, CH3  1.07, s 
  3.40, d (9.2)     
a Measured in CDCl3; 
b Measured in CD3OD. 500 MHz for 
1H NMR; 125 MHz for 
13C NMR.  
Scopararane G (5) was obtained as a colorless oil. The HR-EI-MS (m/z 334.2138, [M]
+, C20H30O4
+; 
calcd 334.2144) indicated a molecular formula of C20H30O4, requiring six unsaturations. The 
1H and 
13C NMR spectra of 5 were similar to those of scopararane F (4), except for the missing signal of the 
oxygenated methylene at [δH 4.13 (d, J = 9.2 Hz), 3.40 (d, J = 9.2 Hz); δC 72.4] in 4, the presence of a 
singlet methyl at [δH 1.07 (s); δC 23.5] in 5, and the replacement from the oxygenated quaternary C-6 at 
(δC 107.2) in 4 to the carbonyl resonance at (δC 210.9) in 5. Based on these spectral data, scopararane G (5) 
was assigned as the ketone derivative of scopararane F (4). HMBC cross-peaks of H-20 with C-1, C-5, 
and C-9, and H-7 with C-6, C-8, and C-9, further confirmed the 20-position of the methyl and 6-position 
of the carbonyl respectively. The entire sequence of H-atoms and the C-skeleton of 5 was established 
by 
1H, 
1H COSY and HMBC (Table 2). The relative configurations of rings A and C were identical to 
those in 4, and the relative configurations of C-7 and C-14 were also identical to those in sphaeropsidin 
E [16] according to NOE results. The absolute stereochemistry of 5 was assigned by comparison its CD 
spectra with those of sphaeropsidin E [16]. Compound 5 showed similar Cotton effect to sphaeropsidin E 
at 277 nm, 250 nm, and 227 nm. Due to the presence of carbonyl in B ring of 5, an additional negative 
Cotton effect was also observed at 342 nm. Based on the evidence above, in addition to biogenetical 
reasons, the absolute stereochemistry of 5 was established as 6R, 8S, 10R, 13R, and 14S. 
2.2. Cytotoxic Activities 
Compounds 1–11 were evaluated for their in vitro cytotoxic activities against three human cell  
lines, including SF-268 (human glioma cell line), MCF-7 (human breast adenocarcinoma cell line) and 
NCI-H460 (human non-small cell lung cancer cell line) by the MTT method. The results of the 
cytotoxicity tests suggested that all the analogues demonstrated quite different cytotoxic activities 
(Table 3). Diaporthein B (9) exhibited strong cytotoxicities against SF-268, MCF-7 and NCI-H460 cell 
growth with IC50 values ranging from 4.4–9.9 μM. Libertellenone A (6) displayed varying cytotoxic 
activities against the three cell lines with IC50 values in the range of 12.0–40.2 μM. Scopararanes C (1) 
and D (2) showed moderate cytotoxic activities against the tumor cell line MCF-7 with IC50 values of 
35.9 μM and 25.6 μM, respectively. The other compounds displayed no appreciable activity, except 
that compounds 3, 5, and 7 showed weak cytotoxic activities against the MCF-7 cell line with IC50 
values of 74.1 μM, 85.5 μM, and 60.1 μM, respectively. Mar. Drugs 2012, 10                 
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Table 3. Cytotoxic activities of compounds 1–11. 
Compounds 
IC50 (μM) 
SF-268 MCF-7  NCI-H460 
1  >100 35.9  >100 
2  43.5 25.6 46.1 
3  >100 74.1  >100 
4  >100 >100 >100 
5  >100 85.5  >100 
6  20.5 12.0 40.2 
7  80.1 60.1  >100 
8  >100 >100 >100 
9  9.2 4.4 9.9 
10  >100 >100 >100 
11  >100 >100 >100 
Cisplatin  4.0 9.2 1.5 
Data for compounds 6 to 11 were taken from [12]. 
By comparing the structures of diaporthein B (9) with diaporthein A (8), scopararane B (7), and 
libertellenone A (6), we found that compound 9 displayed strong analogies with compounds 8 and 7, 
differing only in the presence of a ketone moiety at C-7 replacing a hydroxy group, and a ∆
8, 14 olefinic 
bond instead of a ∆
8, 9 olefinic bond, respectively; compound 9 exhibited high structural similarity with 
compound 6 and the main structural difference between them is at position C-20. It also should be noted 
that the only structural differences between libertellenone A (6) and scopararanes C–E (1–3) are the 
number and positions of hydroxyl groups. All the above suggested that the carbonyl at position C-7, ∆
8,14 
olefinic bond, whether the C-20 methyl forms a furan ring with C-6, C-5, and C-10, and the number and 
positions of hydroxyl groups, might be the important structural factors leading to the distinction of 
their cytotoxicities. Diaporthein B and the 11-dehydroxy derivative of diaporthein B (scopararane A) 
were reported to show significant cytotoxic activities against human cancer cell lines (KB, MCF-7, 
NCI-H187) and nonmalignant Vero cells (African green monkey kidney fibroblasts) [10,17], which 
further demonstrates that the structural features described above are important determinants of 
cytotoxic activity. The target of the cytotoxic effect of these compounds is still unknown. 
3. Experimental Section  
3.1. General Experimental Procedures 
1H, 
13C NMR and DEPT spectra and 2D NMR were recorded on a Bruker Avance-500 spectrometer 
with TMS as internal standard; at 500/125 MHz, respectively; δ in ppm, J in Hz. HR-EI-MS were 
measured on a Thermo MAT95XP High Resolution mass spectrometer and EIMS on a Thermo DSQ EI-
mass spectrometer; in m/z. Optical rotations were measured in methanol using a Perkin-Elmer 341 
polarimeter from Perkin Elmer. CD measurements were carried out under N2 gas on a Jasco 820 
spectropolarimeter. IR spectra were recorded on a Bruker EQUINOX 55 spectrophotometer. UV 
spectra were measured on a Biochrom Ultrospec 6300 pro UV-visible spectrophotometer; λmax (log ε) in 
nm. Column chromatography (CC) was performed with silica gel (SiO2; 200–300 mesh; Qingdao Mar. Drugs 2012, 10                 
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Haiyang Chemical Group Co., Qingdao, China), Chromatorex ODS (40–75 μm; Fuji Silysia), and 
Sephadex LH-20 (Amersham Biosciences). TLC was conducted with precoated glass plates GF-254 
(Qingdao Haiyang Chemical Group Co., Qingdao, China). Melting points were measured with a Netzsch 
DSC 204 apparatus. Solvents were of the industrial purity and distilled prior to use. 
3.2. Fungal Material and Identification 
The strain FS26 was isolated from a marine sediment sample, which was collected at the depth of 
139 m in the South China Sea (18°42.878′N，111°2.797′E), in August 2008. The strain was identified 
by sequence analysis of the rDNA ITS (internal transcribed spacer) region. The sequence of the ITS 
region of the marine fungus E. scoparia FS26 has been submitted to GenBank (Accession   
No. HM989831). By using BLAST (nucleotide sequence comparison program) to search the GenBank 
database,  E. scoparia FS26 has 100% similarity to E. scoparia BAFC 3321 (Accession   
No. EU702431.1). The strain is preserved at the Guangdong Provincial Key Laboratory of Microbiol 
Culture Collection and Application, Guangdong Institute of Microbiology [11,12]. 
3.3. Fermentation, Extraction and Isolation 
E. scoparia FS26 was cultured in potato dextrose broth (potato 20%, glucose 2%, K2HPO4 0.3%, 
MgSO4·7H2O 0.15%, vitamin B1 10 mg/L), which was prepared in 50% (v/v) sea water instead of 
distilled water. The fungus E. scoparia FS26 was maintained on 50% (v/v) sea water potato dextrose 
agar medium at 28 °C for 5 days, and then three pieces (0.5 × 0.5 cm
2) of mycelial agar plugs were 
inoculated into 20 × 500 mL Erlenmeyer flasks, each containing 250 mL 50% (v/v) sea water potato 
dextrose broth. After 6 days of incubation at 28 °C on a rotary shaker at 130 r/m, 25 mL seed cultures 
was aseptically transferred into a total of 200 flasks (1000 mL) containing 500 mL of 50% (v/v) sea 
water potato dextrose broth. The liquid cultivation that followed was kept for 7 days at 28 °C and  
130 r/m on a rotary shaker. 
The culture (100 L) was centrifuged to give the broth and mycelia. The broth was exhaustively 
extracted with EtOAc four times, then the EtOAc layers were combined and evaporated under reduced 
pressure at a temperature not exceeding 40 °C to yield a dark brown gum (24.8 g). Fungal mycelia were 
thoroughly extracted with EtOAc four times and then the extracts were combined and concentrated under 
reduced pressure to give a mycelial crude extract (132.4 g). Both crude EtOAc extracts were subjected to 
silica gel column chromatography (200–300 mesh) with a gradient system of increasing polarity 
(petroleum ether/AcOEt/MeOH), to afford 20 fractions (Fr.A–Fr.V) for the liquid culture and 20 fractions 
for the mycelia (Fr.1–Fr.20), respectively.  
The Fr.F eluting with 15:1 petroleum ether-EtOAc was subjected to CC on Sephadex LH-20 
(CHCl3/MeOH, 1:1), to yield compound 1 (114.2 mg). The Fr.M eluting with 3:1 petroleum   
ether-EtOAc was subjected to CC on Sephadex LH-20 (CHCl3/MeOH, 1:1), to give 2 sub-fractions 
Fr.M-1 and Fr.M-2. Fr.M-2 was first purified by CC over reversed-phase silica gel C18 (MeOH/H2O, 
60:40), then followed by CC (SiO2; petroleum ether/AcOEt, 5:1) to get compound 5 (57.1 mg). The 
Fr.N eluting with 7:3 petroleum ether-EtOAc was subjected to CC on Sephadex LH-20 
(CHCl3/MeOH, 1:1), and then followed by CC over reversed-phase silica gel C18 (MeOH/H2O, 50:50 
to 70:30) to yield compounds 2 (36.6 mg). The Fr.P eluting with 1:1 petroleum ether-EtOAc was Mar. Drugs 2012, 10                 
 
 
548
subjected to CC on Sephadex LH-20 (CHCl3/MeOH, 1:1), and followed by CC over reversed-phase 
silica gel C18 (MeOH/H2O, 40:60 to 60:40) to yield 3 sub-fractions Fr.P-1 to Fr.P-3. Fr.P-2 was further 
purified by CC (SiO2; petroleum ether/AcOEt, 2:1) to get compound 3 (8.0 mg). The Fr.14 eluting 
with 2:1 petroleum ether-EtOAc was subjected to CC on Sephadex LH-20 (CHCl3/MeOH, 1:1), 
followed by CC over reversed-phase silica gel C18 (MeOH/H2O, 70:30) and CC (SiO2; petroleum 
ether/AcOEt, 2:1) to get compound 4 (11.1 mg). 
3.4. Characterization Data 
Scopararane C (1): colorless crystals; mp 170.4 °C; [α]25
 D −160.40 (c 1.53, CHCl3); UV (MeOH) λmax 
(log ε) 219 (3.75), 263 (3.68), 325 (3.92) nm; CD (CH3CN) (∆ε) 352 (−32.4), 308 (+7.3); IR (KBr) vmax 
3528, 3412, 3011, 2954, 2924, 2866, 1652, 1622, 1590, 1462, 1394, 1369, 1287, 1211, 1122, 1085, 
1046, 997, 842, 806, 780, 679, 545 cm
−1; 
1H and 
13C NMR, see Table 1; HR-EI-MS m/z 316.2032 [M]
+ 
(calcd for C20H28O3
+, 316.2033). 
Scopararane D (2): colorless crystals; mp 197.4 °C; [α]25
 D −200.36 (c 0.84, CHCl3); UV (MeOH) 
λmax (log ε) 218 (3.94), 260 (3.81), 325 (4.02) nm; CD (CH3CN) (∆ε) 351 (−37.7), 310 (+9.1); IR 
(KBr) vmax 3522, 3410, 3089, 2968, 2877, 1650, 1620, 1591, 1465, 1392, 1369, 1289, 1231, 1206, 
1142, 1085, 1044, 1012, 957, 919, 878, 806, 780, 679, 548 cm
−1; 
1H and 
13C NMR, see Table 1;  
HR-EI-MS m/z 332.1983 [M]
+ (calcd for C20H28O4
+, 332.1982). 
Scopararane E (3): colorless crystals; colorless crystals; mp 100.0 °C; [α]25
 D −92.30 (c 0.77, MeOH); 
UV (MeOH) λmax (log ε) 218 (4.02), 259 (3.90), 324 (4.12) nm; CD (CH3CN) (∆ε) 350 (−36.4), 312 
(+15.1); IR (KBr) vmax 3417, 3087, 2970, 2941, 2874, 1653, 1622, 1592, 1464, 1396, 1374, 1333, 
1289, 1230, 1153, 1064, 1041, 1017, 1002, 968, 916, 877, 835, 778, 731, 678, 545 cm
−1; 
1H and 
13C NMR, 
see Table 1; HR-EI-MS m/z 371.1833 [M + Na]
+ (calcd for C20H28O5 Na
+, 371.1834). 
Scopararane F (4): colorless crystals; mp 170.0 °C; [α]25
 D −94.70 (c 0.66, MeOH); UV (MeOH) λmax 
(log ε) 207 (3.41) nm; CD (CH3CN) (∆ε) 207 (−103.4); IR (KBr) vmax 3382, 3086, 2932, 1641, 1460, 
1393, 1302, 1247, 1212, 1180, 1125, 1001, 949, 914, 877, 845, 804, 709 cm
−1; 
1H and 
13C NMR, see 
Table 2; HR-EI-MS m/z 373.1984 [M + Na]
+ (calcd for C20H30O5Na
+, 373.1991). 
Scopararane G (5): a colorless oil; [α]25
 D +1.43 (c 0.42, MeOH); UV (MeOH) λmax (log ε) 206 (3.67), 
232 (3.45), 278 (3.21) nm; CD (CH3CN) (∆ε) 342 (−0.8), 277 (+0.4), 250 (−1.1), 227 (+1.8); IR (KBr) 
vmax 3436, 2960, 2928, 2874, 1725, 1461, 1379, 1286, 1125, 1074, 1043, 844, 805, 745 cm
−1; 
1H and 
13C NMR, see Table 2; HR-EI-MS m/z 334.2138 [M]
+ (calcd for C20H30O4
+, 334.2144). 
Libertellenone A (6): colorless crystals; CD (CH3CN) (∆ε) 353 (−46.3), 311 (+13.8). 
3.5. Cytotoxicity Assay 
Cytotoxicities of compounds (1–5) were assayed against three tumor cell lines MCF-7, NCI-H460 
and SF-268. Assays were performed by the MTT method [18]. Mar. Drugs 2012, 10                 
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4. Conclusion 
Investigation of biologically active secondary metabolites from the marine-derived fungus 
Eutypella scoparia in the South China Sea has resulted in the isolation of five novel oxygenated 
pimarane diterpenes, scopararanes C–G (1–5). Cytotoxic tests for the five novel compounds (1–5) and 
their related six analogues [12] displayed quite different cytotoxic activities. Study of the   
structure-activity relationship indicated that the carbonyl at position C-7, ∆
8, 14 olefinic bond, whether 
the C-20 methyl forms a furan ring with C-6, C-5, and C-10, and the number and positions of hydroxyl 
groups might be the important structural factors leading to the distinction of their cytotoxicities. 
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